Peter Newham

3.3k total citations · 1 hit paper
38 papers, 2.6k citations indexed

About

Peter Newham is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Peter Newham has authored 38 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Immunology and Allergy and 12 papers in Immunology. Recurrent topics in Peter Newham's work include Cell Adhesion Molecules Research (15 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Response and Inflammation (6 papers). Peter Newham is often cited by papers focused on Cell Adhesion Molecules Research (15 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Response and Inflammation (6 papers). Peter Newham collaborates with scholars based in United Kingdom, United States and Netherlands. Peter Newham's co-authors include Martin J. Humphries, Sarah Brockbank, Simon W. Jones, Stephanie Raines, Omar Sharif, Neil D. Perkins, В. Н. Большаков, Mark A. Lindsay, M. Needham and A. Paul Mould and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Peter Newham

37 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving role of investigative toxicology in the pharmaceutical industry

2023 132 citations Peter Newham et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Newham United Kingdom	23	1.2k	531	516	456	376	38	2.6k
Jeffrey R. Weidner United States	18	934 0.8×	604 1.1×	317 0.6×	439 1.0×	638 1.7×	39	2.7k
Atsushi Irie Japan	33	1.9k 1.6×	806 1.5×	483 0.9×	276 0.6×	110 0.3×	89	3.7k
Phillip S. Leventhal United States	25	1.1k 0.9×	386 0.7×	341 0.7×	112 0.2×	156 0.4×	45	2.4k
Tae Jin Kim South Korea	29	1.1k 0.9×	698 1.3×	270 0.5×	257 0.6×	77 0.2×	122	2.6k
Saverio Francesco Retta Italy	36	1.6k 1.3×	358 0.7×	793 1.5×	276 0.6×	80 0.2×	83	3.9k
Panagiotis S. Kabouridis United Kingdom	22	1.5k 1.3×	1.5k 2.8×	161 0.3×	141 0.3×	347 0.9×	37	3.1k
Astrid Kehlen Germany	32	1.3k 1.1×	448 0.8×	136 0.3×	299 0.7×	152 0.4×	71	2.9k
Ahuva Nissim United Kingdom	28	1.4k 1.2×	655 1.2×	217 0.4×	101 0.2×	394 1.0×	60	3.1k
Takako Hirata Japan	25	831 0.7×	1.2k 2.3×	646 1.3×	170 0.4×	82 0.2×	50	2.7k
Fredrik Ivars Sweden	27	1.2k 1.0×	2.1k 3.9×	243 0.5×	276 0.6×	163 0.4×	68	3.5k

Countries citing papers authored by Peter Newham

Since Specialization

Citations

This map shows the geographic impact of Peter Newham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Newham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Newham more than expected).

Fields of papers citing papers by Peter Newham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Newham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Newham. The network helps show where Peter Newham may publish in the future.

Co-authorship network of co-authors of Peter Newham

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Newham. A scholar is included among the top collaborators of Peter Newham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Newham. Peter Newham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Contrepois, Kévin, Zenta Tsuchihashi, Kazuishi Kubota, et al.. (2025). Abstract 6364: Serum proteomics analysis: Potential biomarkers and mechanisms of trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis (ILD). Cancer Research. 85(8_Supplement_1). 6364–6364.

Tsuchihashi, Zenta, Kévin Contrepois, Kazuishi Kubota, et al.. (2025). Abstract 5928: Baseline serum protein analysis of patients with interstitial lung disease/pneumonitis (ILD) in 3 trastuzumab deruxtecan (T-DXd) trials: DESTINY-Breast01, DESTINY-Breast04, and DESTINY-Lung01. Cancer Research. 85(8_Supplement_1). 5928–5928. 1 indexed citations

Lua, Ingrid, Jeff Chen, Kévin Contrepois, et al.. (2024). Abstract LB417: Leveraging advanced human lung models to explore mechanisms underlying T-DXd-associated interstitial lung disease (ILD). Cancer Research. 84(7_Supplement). LB417–LB417. 1 indexed citations

Carss, Keren, Aimée M. Deaton, Alberto Del Río-Espínola, et al.. (2022). Using human genetics to improve safety assessment of therapeutics. Nature Reviews Drug Discovery. 22(2). 145–162. 42 indexed citations

Crosby, Priya, Ryan Hamnett, Marrit Putker, et al.. (2019). Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time. Cell. 177(4). 896–909.e20. 218 indexed citations

Newham, Peter, Daniel W. Ross, Shampa Das, et al.. (2013). Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis. Inflammation Research. 63(2). 149–160. 19 indexed citations

Baker, Natasha, Paul T. Sharpe, Kirsty L. Culley, et al.. (2012). Dual regulation of metalloproteinase expression in chondrocytes by Wnt‐1–inducible signaling pathway protein 3/CCN6. Arthritis & Rheumatism. 64(7). 2289–2299. 31 indexed citations

Newham, Peter, Shampa Das, John Kemp, et al.. (2011). Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab. Critical Care. 15(S1). 2 indexed citations

Newham, Peter, John Yates, Shampa Das, et al.. (2011). Preclinical pharmacodynamics and safety profiling of AZD9773: A novel anti-TNF-α polyclonal immune ovine Fab similar to D-CytoFab. 2. 1 indexed citations

10.

Blom, Arjen B., Sarah Brockbank, P.L. van Lent, et al.. (2009). Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt‐induced signaling protein 1. Arthritis & Rheumatism. 60(2). 501–512. 195 indexed citations

11.

Jones, Simon W., Gareth M. Watkins, Stephanie Roberts, et al.. (2008). The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-α and MMP13. Osteoarthritis and Cartilage. 17(4). 464–472. 274 indexed citations

12.

Booth, George, et al.. (2008). Gene expression profiles at different stages of collagen-induced arthritis. Autoimmunity. 41(7). 512–521. 24 indexed citations

13.

Sharif, Omar, В. Н. Большаков, Stephanie Raines, Peter Newham, & Neil D. Perkins. (2007). Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunology. 8(1). 1–1. 397 indexed citations

14.

Humphries, Martin J., J. M. Sheridan, A. Paul Mould, & Peter Newham. (2007). Mechanisms of VCAM‐1 and Fibronectin Binding to Integrin α ₄ β ₁ : Implications for Integrin Function and Rational Drug Design. Novartis Foundation symposium. 189. 177–199. 8 indexed citations

15.

Jones, Simon W., et al.. (2006). The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. Osteoarthritis and Cartilage. 14(6). 597–608. 41 indexed citations

16.

Sharpe, Paul T., et al.. (2002). Expression and purification of biologically active IGF-binding proteins using the LCR/Mel expression system. Protein Expression and Purification. 27(1). 1–11. 5 indexed citations

17.

Cosulich, Sabina, et al.. (2000). A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin. Carcinogenesis. 21(9). 1757–1760. 14 indexed citations

18.

Newham, Peter, Sue E. Craig, Katherine Clark, A. Paul Mould, & Martin J. Humphries. (1998). Analysis of Ligand-Induced and Ligand-Attenuated Epitopes on the Leukocyte Integrin α4β1: VCAM-1, Mucosal Addressin Cell Adhesion Molecule-1, and Fibronectin Induce Distinct Conformational Changes. The Journal of Immunology. 160(9). 4508–4517. 33 indexed citations

19.

Newham, Peter, Susan E. Craig, Amanda Rees, et al.. (1997). α4 Integrin Binding Interfaces on VCAM-1 and MAdCAM-1. Journal of Biological Chemistry. 272(31). 19429–19440. 80 indexed citations

20.

Newham, Peter, Janet A. Askari, John M. Clements, et al.. (1994). Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1.. Journal of Biological Chemistry. 269(6). 4005–4011. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact